Volume 12, Issue 12 (February 2019)
Qom Univ Med Sci J 2019, 12(12): 1-13 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rahmani M, Tafvizi F, Kamali K. Association of Matrix metalloproteinases-9 -1562 C>T and susceptibility to bladder cancer. Qom Univ Med Sci J 2019; 12 (12) :1-13
URL: http://journal.muq.ac.ir/article-1-2239-en.html
URL: http://journal.muq.ac.ir/article-1-2239-en.html
1- Department of Biology, Parand Branch, Islamic Azad University
2- Department of Biology, Parand Branch, Islamic Azad University ,farzanehtafvizi54@gmail.com
3- Department of Urology, Hashemi Nejad Hospital, Iran University of Medical Sciences
2- Department of Biology, Parand Branch, Islamic Azad University ,
3- Department of Urology, Hashemi Nejad Hospital, Iran University of Medical Sciences
Abstract: (5123 Views)
Background and Objectives: Bladder cancer (BC) is one of the most common malignant diseases worldwide. The incidence rate of this cancer has been reported three times more in men than in women. Matrix metalloproteinases play an important role in the development and progression of this cancer. In the current study, the polymorphism of matrix metalloproteinase-9 (MMP-9) gene promoter and risk of to bladder cancer were investigated.
Methods: In this case-control study, 141 patients with bladder cancer and 135 healthy subjects were studied. First, DNA extraction was performed, then, PCR was carried out using MMP-9 specific primers. RFLP method was used to investigate the -1562 C>T polymorphism. The association between MMP-9 polymorphism and risk of bladder cancer was determined using chi square method and GraphPad Prism software (version 6.01). The Hardy-Weinberg equilibrium was calculated using POPGENE software (version 1.32), Confidence Interval (CI), and Odds Ratio (OR). The significance level was considered to be p<0.05.
Results: In this study, there was no significant association between MMP-9 polymorphism and risk for bladder cancer (p>0.05). No significant association was found between the genotypes and stage, grade of disease, and size of tumor. There was also no significant association between smoking and grade of disease, size of tumor, and stage of the disease. A three-fold risk of bladder cancer was associated with smoking.
Conclusion: Based on the results of this study, genetic variation in -1562 C>T polymorphism of MMP-9 gene promotor had no association with the risk of bladder cancer. Therefore, smoking should be considered as an important risk factor for bladder cancer.
Methods: In this case-control study, 141 patients with bladder cancer and 135 healthy subjects were studied. First, DNA extraction was performed, then, PCR was carried out using MMP-9 specific primers. RFLP method was used to investigate the -1562 C>T polymorphism. The association between MMP-9 polymorphism and risk of bladder cancer was determined using chi square method and GraphPad Prism software (version 6.01). The Hardy-Weinberg equilibrium was calculated using POPGENE software (version 1.32), Confidence Interval (CI), and Odds Ratio (OR). The significance level was considered to be p<0.05.
Results: In this study, there was no significant association between MMP-9 polymorphism and risk for bladder cancer (p>0.05). No significant association was found between the genotypes and stage, grade of disease, and size of tumor. There was also no significant association between smoking and grade of disease, size of tumor, and stage of the disease. A three-fold risk of bladder cancer was associated with smoking.
Conclusion: Based on the results of this study, genetic variation in -1562 C>T polymorphism of MMP-9 gene promotor had no association with the risk of bladder cancer. Therefore, smoking should be considered as an important risk factor for bladder cancer.
Type of Study: Original Article |
Subject:
ژنتیک
Received: 2018/09/15 | Accepted: 2018/12/11 | Published: 2019/05/8
Received: 2018/09/15 | Accepted: 2018/12/11 | Published: 2019/05/8
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2008-1375
pISSN: 1735-7799
Email: journal[at]muq.ac.ir
j.mua.ac[at]gmail.com
